Results 131 to 140 of about 654,709 (293)
A future cities survey research design for policy analysis [PDF]
Kenneth L. Kraemer+4 more
openalex +1 more source
Transient receptor potential melastatin‐4 (TRPM4) is overexpressed in prostate cancer (PCa). Knockout of TRPM4 resulted in reduced PCa tumor spheroid size and decreased PCa tumor spheroid outgrowth. In addition, lack of TRPM4 increased cell death in PCa tumor spheroids.
Florian Bochen+6 more
wiley +1 more source
Background Randomised controlled trials (‘trials’) are susceptible to poor participant recruitment and retention. Studies Within A Trial are the strongest methods for testing the effectiveness of strategies to improve recruitment and retention.
Adwoa Parker+18 more
doaj +1 more source
Design of Pneumaniez and Researches on its Characteristics
Y. Niitsu, M. Kurahashi
openalex +2 more sources
Evaluating a school health program focused on high absence pupils: a research design. [PDF]
Robert W. Tuthill+3 more
openalex +1 more source
Pancreatic ductal adenocarcinoma (PDAC) is a disease with very poor prognosis due to therapeutic limitations. We investigated the antitumor effects of cystatin A (CSTA) in PDAC murine models. We are first to confirm that CSTA enhances T helper type 1‐mediated antitumor effects through promotion of dendritic cells and M1 macrophage activity. CSTA can be
Alessandro Nasti+8 more
wiley +1 more source
1) RESEARCH ON SHELL FOUNDATIONS EXPERIMENTS, THEORY, DESIGN, CONSTRUCTION, AND APPLICATIONS
Kazuo Minami
openalex +2 more sources
Design Status of a Separated-Sector Cyclotron Booster Accelerator for the Holifield Heavy Ion Research Facility [PDF]
J.A. Martin+5 more
openalex +1 more source
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source